文献速递腹部技术与安全CT

双能CT定量血液病患者肝脏铁含量

Dual-energy CT for liver iron quantification in patients with haematological disorders.
PubMed 文献 · Eur Radiol · 2018-11-07

回顾性分析110例血液病患者147次连续双源双能量非增强胸部CT,经软件原型行物质分解生成铁增强图并计算虚拟铁含量(VIC)。输血组VIC中位数1.33 mg/ml,对照组0.61 mg/ml;VIC与血清铁蛋白(r=0.623,p<0.001)及估计输血铁量(r=0.681,p<0.001)均强相关,作者认为可用于输血性含铁血黄素沉着的补充评估。

要点

  • 胸部双能CT物质分解可生成铁增强图并测得肝脏虚拟铁含量(VIC,单位mg/ml)。
  • VIC与血清铁蛋白强相关(r=0.623,p<0.001),与估计输血铁量亦强相关(r=0.681,p<0.001)。
  • 作者认为VIC可用于血液病患者输血性含铁血黄素沉着的补充评估。

核心结论

  • 经双能胸部CT方案获得的肝脏虚拟铁含量与血清铁蛋白水平及估计输血铁量强相关,作者认为因此可用于输血性含铁血黄素沉着的常规诊断补充评估。

研究设计与样本

  • 回顾性研究,纳入2016年9月至2017年6月110例血液病患者的147次连续双源双能量非增强胸部CT,主要用于排除肺部感染;图像经软件原型后处理行物质分解生成铁增强图,勾画自由手ROI计算VIC(mg/ml),并与血清铁蛋白及估计输血铁量做相关分析;未接受血制品的患者扫描作为对照。

关键影像表现/征象

  • 经物质分解生成铁增强图,勾画包含大部分部分显示肝脏的自由手ROI计算虚拟铁含量(VIC),以mg/ml表示。

诊断标准与关键数值

  • 输血后组血清铁蛋白中位数138.0 μg/dl(范围6.0-2628.0 μg/dl),VIC中位数1.33 mg/ml(范围-0.94-7.56 mg/ml)。
  • 对照组血清铁蛋白中位数27.0 μg/dl(范围1.0-248.0 μg/dl),VIC中位数0.61 mg/ml(范围-2.1-2.4)。
  • 血清铁蛋白与VIC强相关(r=0.623;p<0.001),血清铁蛋白与估计输血铁量亦强相关(r=0.681;p<0.001)。

临床应用与阅片要点

  • 作者认为肝脏VIC可用于血液病患者输血性含铁血黄素沉着的补充评估。
  • VIC测量在主要用于排除肺部感染的常规胸部CT上进行,可包含部分显示的肝脏。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To retrospectively quantify liver iron content in haematological patients suspected of transfusional haemosiderosis using dual-energy CT (DECT) and correlate with serum ferritin levels and estimated quantity of transfused iron.

METHODS: One hundred forty-seven consecutive dual-source dual-energy non-contrast chest-CTs in 110 haematologic patients intended primarily for exclusion of pulmonary infection between September 2016 and June 2017 were retrospectively evaluated. Image data was post-processed with a software prototype. After material decomposition, an iron enhancement map was created and freehand ROIs were drawn including most of the partially examined liver. The virtual iron content (VIC) was calculated and expressed in milligram/millilitre. VIC was correlated with serum ferritin and estimated amount of transfused iron. Scans of patients who had not received blood products were considered controls.

RESULTS: Forty-eight (32.7%) cases (controls) had not received any blood transfusions whereas 67.3% had received one transfusion or more. Median serum ferritin and VIC were 138.0 μg/dl (range, 6.0-2628.0 μg/dl) and 1.33 mg/ml (range, - 0.94-7.56 mg/ml) in the post-transfusional group and 27.0 μg/dl (range, 1.0-248.0 μg/dl) and 0.61 mg/ml (range, - 2.1-2.4) in the control group. Correlation between serum ferritin and VIC was strong (r = 0.623; p < 0.001) as well as that between serum ferritin and estimated quantity of transfused iron (r = 0.681; p < 0.001).

CONCLUSIONS: Hepatic VIC obtained via dual-energy chest-CT examinational protocol strongly correlates with serum ferritin levels and estimated amount of transfused iron and could therefore be used in the routine diagnosis for complementary evaluation of transfusional haemosiderosis.

KEY POINTS: • Virtual liver iron content was measured in routine chest-CTs of haematological patients suspected of having iron overload. Chest-CTs were primarily intended for exclusion of pulmonary infection. • Measurements correlate strongly with the most widely used blood marker of iron overload serum ferritin (after exclusion of infection) and the amount of transfused iron. • Liver VIC could be used for supplemental evaluation of transfusional haemosiderosis in haematological patients.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Werner S, Krauss B, Haberland U, et al. Dual-energy CT for liver iron quantification in patients with haematological disorders. Eur Radiol. 2018. PMID: 30406312. doi:10.1007/s00330-018-5785-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。